Natera, Inc. (NASDAQ:NTRA) Given Consensus Recommendation of “Buy” by Analysts
Shares of Natera, Inc. (NASDAQ:NTRA – Get Free Report) have been assigned an average rating of “Buy” from the seventeen brokerages that are covering the stock, Marketbeat.com reports. Seventeen analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have covered the stock in the last year is […]
More Stories
Reviewing Liquidia (NASDAQ:LQDA) & Lifecore Biomedical (NASDAQ:LFCR)
Liquidia (NASDAQ:LQDA – Get Free Report) and Lifecore Biomedical (NASDAQ:LFCR – Get Free Report) are both small-cap medical companies, but...
Head to Head Analysis: Taisei (OTCMKTS:TISCF) & Energy Services of America (NASDAQ:ESOA)
Taisei (OTCMKTS:TISCF – Get Free Report) and Energy Services of America (NASDAQ:ESOA – Get Free Report) are both industrials companies,...
Head-To-Head Comparison: U-BX Technology (NASDAQ:UBXG) vs. Quantum Computing (NASDAQ:QUBT)
U-BX Technology (NASDAQ:UBXG – Get Free Report) and Quantum Computing (NASDAQ:QUBT – Get Free Report) are both small-cap business services...
Susquehanna Bancshares (NASDAQ:SUSQ) versus Synovus Financial (NYSE:SNV) Financial Analysis
Susquehanna Bancshares (NASDAQ:SUSQ – Get Free Report) and Synovus Financial (NYSE:SNV – Get Free Report) are both finance companies, but...
Scotiabank Downgrades Blueprint Medicines (NASDAQ:BPMC) to Hold
Blueprint Medicines (NASDAQ:BPMC – Get Free Report) was downgraded by analysts at Scotiabank from a “strong-buy” rating to a “hold”...
Research Analysts Issue Forecasts for GIII Q1 Earnings
G-III Apparel Group, Ltd. (NASDAQ:GIII – Free Report) – Analysts at Telsey Advisory Group issued their Q1 2027 EPS estimates...